Intestinal Permeability Clinical Trial
Official title:
Methods to Examine Intestinal Permeability Under Different Conditions
Rationale: Intestinal permeability of subjects can vary depending on their health status. It
is therefore important to be able to measure and quantify intestinal permeability in a
standardized way. Subjects with intestinal complaints (like irritable bowel disorder) or
obese subjects have been found to have increased intestinal permeability. Different
physiological conditions might affect intestinal permeability (IP) further.
In the clinic, sugar absorption tests and different blood and urine markers have been used
to quantify IP. The sugars sucrose, mannitol, sucralose and lactulose are absorbed
differently in the small or large intestines, resulting in different sugar levels in urine.
This indicates the level of intestinal permeability and the location of increased
permeability which is more or less permeable.
A high-fat meal could be used as a challenge test to increase IP in subjects even further.
After a high fat meal, lipopolysaccharide (LPS) could be co-transported with chylomicrons.
Small amounts of LPS co-transit with dietary fat from the gut after a high-fat meal, which
thereby increases plasma LPS concentrations.
Because of the above mentioned reasons, it could be relevant to determine intestinal
permeability and plasma LPS concentration after consumption of a high-fat diet.
Different methods will be used to determine the intestinal permeability in lean and obese
men, under different conditions. New parameters, like intestinal (I) fatty acid binding
protein (I-FABP), liver (L)-FABP, LPS and inflammatory markers will be measured and related
to outcomes of tests, to examine the relation with intestinal permeability.
The association of IP with whole body electrical resistance will be examined, to determine
usefulness of a candidate non-invasive method for IP investigation.
Study design: The study is designed as a randomized, cross-over and open study.
Study population: 16 healthy, lean (BMI 20-25 kg.m-2) and obese (BMI 30-35 kg.m-2) male
subjects will participate in the study, aged between 18-45 years.
Intervention: On two different test days eight lean and eight obese men will be supplied
with a sugar drink to examine intestinal permeability under normal conditions and in
combination with an oral fat load to examine intestinal permeability under stressed
conditions.
Main study parameters/endpoints: Intestinal permeability will be examined with an absorption
test using four different sugars (sucrose, mannitol, sucralose and lactulose). New markers
of intestinal permeability, like I-FABP, L-FABP, LPS and inflammatory markers will be
measured as well.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Basic Science
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03957239 -
The Effect of a Cranberry Beverage on Intestinal Permeability and Gastrointestinal Function in Generally Healthy Adults
|
N/A | |
Recruiting |
NCT04543877 -
WHNRC (Western Human Nutrition Research Center) Fiber Intervention Study
|
Early Phase 1 | |
Recruiting |
NCT04109352 -
Labelled Carbon Sucrose Breath Test (13C-SBT) as a Marker of Environmental Enteropathy
|
||
Completed |
NCT01424306 -
Diet and Systemic Inflammation
|
N/A | |
Completed |
NCT01241201 -
Intestinal Barrier Function and Probiotics.
|
N/A | |
Completed |
NCT01477034 -
Vitamin D and Adipose Tissue Inflammation
|
N/A | |
Recruiting |
NCT05257200 -
Gut Permeability and Bariatric-metabolic Surgery
|
||
Completed |
NCT03027583 -
The Effect of Probiotic Intervention on Intestinal Permeability
|
N/A | |
Completed |
NCT03704727 -
The Effects of Probiotics on Intestinal Permeability in Gastrointestinal Cancer Patients in Chemotherapy
|
N/A | |
Recruiting |
NCT04979130 -
Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)
|
Phase 4 | |
Recruiting |
NCT06262880 -
Dietary Supplementation on Gastrointestinal Barrier Function
|
N/A | |
Completed |
NCT01756040 -
Intestinal Permeability in Preterm Infants
|
Phase 1 | |
Active, not recruiting |
NCT04083950 -
Induction of Gut Permeability by an Oral Vaccine
|
Early Phase 1 | |
Completed |
NCT03113240 -
Trial of Enteral Glutamine on Intestinal Permeability in Critically Ill Patients
|
Phase 3 |